WuXi Biologics (02269) Announces Share Capital Increase Through Option Exercises

Bulletin Express

Nov 28, 2025

According to the latest disclosure, WuXi Biologics (02269) increased its issued ordinary shares from 4,117,744,981 to 4,128,113,981 as of November 28, 2025. The change involved the exercise of share options under the company’s Pre-IPO Share Option Scheme adopted on January 5, 2016 (amended on August 10, 2016).

On November 27, 2025, 165,000 new shares were issued at HKD1.74. On November 28, 2025, 145,000 new shares were issued at HKD1.48, and an additional 10,059,000 shares were issued at HKD1.29. The transactions were duly authorized by the company’s board and complied with all relevant requirements. The final total of issued shares stands at 4,128,113,981.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1112026756"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1112026756\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1112026756?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-28 20:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1112026756","market":"us","top_or_hot":-1,"title":"WuXi Biologics (02269) Announces Share Capital Increase Through Option Exercises","media":"Bulletin Express","content":"<p>According to the latest disclosure, WuXi Biologics (02269) increased its issued ordinary shares from 4,117,744,981 to 4,128,113,981 as of November 28, 2025. The change involved the exercise of share options under the company’s Pre-IPO Share Option Scheme adopted on January 5, 2016 (amended on August 10, 2016).</p>\n<p>On November 27, 2025, 165,000 new shares were issued at HKD1.74. On November 28, 2025, 145,000 new shares were issued at HKD1.48, and an additional 10,059,000 shares were issued at HKD1.29. The transactions were duly authorized by the company’s board and complied with all relevant requirements. The final total of issued shares stands at 4,128,113,981.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>WuXi Biologics (02269) Announces Share Capital Increase Through Option Exercises</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWuXi Biologics (02269) Announces Share Capital Increase Through Option Exercises\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-28 20:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>According to the latest disclosure, WuXi Biologics (02269) increased its issued ordinary shares from 4,117,744,981 to 4,128,113,981 as of November 28, 2025. The change involved the exercise of share options under the company’s Pre-IPO Share Option Scheme adopted on January 5, 2016 (amended on August 10, 2016).</p>\n<p>On November 27, 2025, 165,000 new shares were issued at HKD1.74. On November 28, 2025, 145,000 new shares were issued at HKD1.48, and an additional 10,059,000 shares were issued at HKD1.29. The transactions were duly authorized by the company’s board and complied with all relevant requirements. The final total of issued shares stands at 4,128,113,981.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02269","symbol_name":"药明生物","start_time":0,"source_url":"","article_id":"1112026756","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1112026756","pubTimestamp":1764333797,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"According to the latest disclosure, WuXi Biologics (02269) increased its issued ordinary shares from 4,117,744,981 to 4,128,113,981 as of November 28, 2025. The change involved the exercise of share...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02269":"药明生物"},"translate_title":"药明生物(02269)公布透过行使购股权增加股本","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02269":1},"content_text":"According to the latest disclosure, WuXi Biologics (02269) increased its issued ordinary shares from 4,117,744,981 to 4,128,113,981 as of November 28, 2025. The change involved the exercise of share options under the company’s Pre-IPO Share Option Scheme adopted on January 5, 2016 (amended on August 10, 2016).\nOn November 27, 2025, 165,000 new shares were issued at HKD1.74. On November 28, 2025, 145,000 new shares were issued at HKD1.48, and an additional 10,059,000 shares were issued at HKD1.29. The transactions were duly authorized by the company’s board and complied with all relevant requirements. The final total of issued shares stands at 4,128,113,981.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}